Y-Mabs Therapeutics (YMAB) Revenue (2018 - 2025)
Y-Mabs Therapeutics (YMAB) revenue from Sep 30, 2018 to Jun 30, 2025. The TTM Y-Mabs Therapeutics (YMAB) revenue is $85M. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Y-Mabs Therapeutics (YMAB) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.34% |
| 3 Years TTM | +28.91% |
Annual Revenue change of Y-Mabs Therapeutics (YMAB)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $40M | -53.91% |
| 2024 | $88M | +3.38% |
| 2023 | $85M | +29.95% |
| 2022 | $65M | +87.02% |
| 2021 | $35M | +68.19% |
| 2020 | $21M | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |